Study Evaluating the Safety and Efficacy of an ECM Hydrogel for the Treatment of Anorectal Fistulas

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorECM Therapeutics, Inc.

About this trial

Safety and Efficacy of ECMT-100 for the Treatment of Anorectal Fistulas

Eligibility criteria

Qualifiers

Male and female subjects at least 18 years of age.

Provide informed consent

Non-pregnant females

Clinical diagnosis of 1 high transsphincteric anorectal fistula, with 1 internal opening and 1-2 external openings, with a single seton in place.

Disqualifiers

Inability to provide informed consent.

Medical history of Crohn's disease/Ulcerative Colitis.

Subjects with multiple fistula tracts (defined as >1 internal opening and/or >2 external openings), secondary tracts, horseshoe fistulas, J-pouch fistulas, superficial fistulas, ano/recto-vaginal fistulas or rectourethral fistulas.

Previous fistulotomy/fistulectomy at the target treatment site (a history of these procedures at other locations is not exclusionary).

Trial design

Treatments tested in this trial

  • ECMT-100

Treatment groups

10 Participants
are divided into 1 treatment group

Sponsors and collaborators